In Zhu et al, 23 of the 44 GCT cases had RANKL-positive STCs and 10 cases exhibited RANKL-positive MGCs, with a positive rate of 52 and 23%, respectively. This evidence concerns the gene TNFSF11 and granular cell tumor.